GlassScriptPhysician profile
Danielle Anne Bauer
NPI 1740090448
$1,052.73
in general payments reported to CMS, 2019-2025
14 companies · $1,053 in 2025
The $1,053 reported for 2025 was more than what 86% of Nurse Practitioner providers received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2025: $1,053.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,053.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,052.73 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Cvrx, INC. | $495.72 | 2025 | Barostim Neo System |
| Gilead Sciences, INC. | $126.37 | 2025 | |
| Actelion Pharmaceuticals US, INC. | $83.68 | 2025 | Opsynvi, Uptravi |
| Boehringer Ingelheim Pharmaceuticals, INC. | $55.79 | 2025 | Jardiance |
| Merck Sharp & Dohme LLC | $51.04 | 2025 | Winrevair, Verquvo, Capvaxive |
| Viiv Healthcare Company | $45.08 | 2025 | Apretude |
| Bayer Healthcare Pharmaceuticals INC. | $35.07 | 2025 | |
| Pfizer INC. | $31.66 | 2025 | |
| Medtronic, INC. | $29.09 | 2025 | Linq II |
| Boston Scientific Corporation | $28.46 | 2025 | Cds - Mct/Cem Monitoring |
| Lilly USA, LLC | $22.75 | 2025 | Mounjaro |
| Astrazeneca Pharmaceuticals LP | $21.19 | 2025 | Airsupra |
| Philips North America LLC | $19.40 | 2025 | Extended Holter |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $7.43 | 2025 | Lifevest |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Danielle Bauer listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.